Selected papers
Domènech-Vilardell A, Bajén MT, Benítez AM, Ricart Y, Mora J, Rodríguez-Bel L, García-Tejedor A, Climent J, López-Ojeda A, Urruticoechea A, Martín-Comín J. Removal of the internal mammary sentinel node in breast cancer. Nucl Med Commun. 2009 Dec;30(12):962-70.
Pernas S, Gil M, Benítez A, Bajen MT, Climent F, Pla MJ, Benito E, Gumà A, Gutierrez C, Pisa A, Urruticoechea A, Pérez J, Gil Gil M. Avoiding Axillary Treatment in Sentinel Lymph Node Micrometastases of Breast Cancer: A Prospective Analysis of Axillary or Distant Recurrence. Ann Surg Oncol. 2009 Nov 14. [Epub ahead of print]
Fernández-Ramires R, Solé X, De Cecco L, Llort G, Cazorla A, Bonifaci N, Garcia MJ, Caldés T, Blanco I, Gariboldi M, Pierotti MA, Pujana MA, Benítez J, Osorio A. Gene expression profiling integrated into network modelling reveals heterogeneity in the mechanisms of BRCA1 tumorigenesis. Br J Cancer. 2009 Oct 20;101(8):1469-80.
Puig T, Turrado C, Benhamú B, Aguilar H, Relat J, Ortega-Gutiérrez S, Casals G, Marrero PF, Urruticoechea A, Haro D, López-Rodríguez ML, Colomer R. Novel Inhibitors of Fatty Acid Synthase with Anticancer Activity. Clin Cancer Res. 2009 Dec 15;15(24):7608-7615.
Solé X, Bonifaci N, López-Bigas N, Berenguer A, Hernández P, Reina O, Maxwell CA, Aguilar H, Urruticoechea A, de Sanjosé S, Comellas F, Capellá G, Moreno V, Pujana MA. Biological convergence of cancer signatures. PLoS One. 2009;4(2):e4544.
Predictive models of breast cancer risk associted to BRCA 1 & 2 and their modifiers
